🥳 Proud to be part of this work from @uq_news revealing a crucial link between the brain’s cleaning system and deterioration of neurons associated with Alzheimer’s disease https://t.co/Oxg2mfJjOZ
📄 Full paper: https://t.co/IlRRYX8xjT
#Alzheimers#Neuroscience
🚨Donanemab has been approved for use in Aus. ADNeT Director Prof Chris Rowe said "Today is a momentous day in the treatment of the most common form of dementia. We must now ensure our health system is ready to bring these new treatments to patients" More➡️https://t.co/U9VuFyHtxs
Qinwen Queen of Paris! 👑🥇
Qinwen Zheng becomes the first Chinese player to ever win a singles gold medal at the Olympic Tennis Event!
#Paris2024 | #Olympics | #tennis
We at Rowe Lab are very proud that our PET expert, @vincentDore2 was awarded the prestigious de Leon Prize, as senior author of “CenTauR: Toward a universal scale and masks for standardizing tau imaging studies”. Time to celebrate this great achievement! #AAIC24#AIC
There is an opportunity to apply for an international PhD scholarship at QIMRB within my group in Brisbane. Including the use of genetics and other biomarkers for early detection of Alzheimer's disease. Feel free to get in touch with any questions!
https://t.co/13k9Jg1X7s
Results of a new study show that atrophying of the basal forebrain, a key brain region for learning and memory and part of the cholinergic system, could indicate the presence of Alzheimer's disease well before symptoms occur. ➡️ https://t.co/vatvNlamCJ @CSIRO@TheFlorey@UniMelb
Check out our new paper in #Neurology!
We explored how amyloid-related atrophy in the basal forebrain correlates with cognitive decline in early Alzheimer's, using AIBL data. Discover distinct impacts on memory and attention.
#ENDALZ#Alzheimers
https://t.co/0W8zGn9JwJ
🌊🏄♀️ Exciting news! A postdoctoral opportunity is now available in my team in Melbourne! Join us and contribute to cutting-edge research in imaging the aging brain. #postdocopportunity#scienceAustralia 🏖️🐨🦘
https://t.co/OltJIZdnqT
Artificial intelligence is more than ChatGPT. It may hold one of the keys to diagnosis, treatment & management of Alzheimer’s disease. @CSIRO ’s Australian e-Health Research Centre new report, AI Trends for Healthcare shows how CSIRO applies AI in research https://t.co/zy9aZemlfB
Excited to share my final PhD chapter now published in @IJBNPA! We explored whether 24hr time use is associated with brain vol, and whether brain vol moderates the time use - cognition relationship in older adults 🧠 🏃♀️ 😴 posting code on GitHub soon!
https://t.co/Ixt83nl0LU
How is ChatGPT transforming the postdoc experience?
Around one in three respondents to Nature’s global postdoc survey are using AI chatbots to help to refine text, generate or edit code, wrangle the literature in their field and more https://t.co/InUkGy1tOW
🎉 Exciting News! Our @nhmrc Ideas project has been funded to explore new insights into the cholinergic system in early Alzheimer's disease with novel PET imaging, in collaboration with @ehealthresearch, @QIMRBerghofer, University of Queensland and many others!!! 🙏
#Alzheimers
Join the ADNeT Early-Mid Career Researcher Group for their next webinar "The journey from postdoc to principal investigator". A fantastic selection of esteemed speakers from Aus & the UK sharing their knowledge of becoming independent researchers.When: 31st October, from 5pmAEST
🧠 How does the basal forebrain change in normal aging and Alzheimer’s disease? 🧠
Check out our new paper that reveals the patterns of volume loss in the cholinergic system over 14 years in 516 old adults from AIBL.
#ENDALZ#Alzheimers
https://t.co/bLEfoc9knv